Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01309
http://purl.obolibrary.org/obo/dinto_DB01309
|
|---|---|
| Preferred Name | insulin glulisine |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | insulin glulisine
|
|---|---|
| label | insulin glulisine
|
| ATCCode | A10AB06
|
| Definition | Insulin glulisine is a biosynthetic, rapid-acting human insulin analogue produced in a non-pathogenic laboratory strain of _Escherichia coli_ (K12). This recombinant hormone differs from native human insulin in that the amino acid arginine at position B3 is replaced by lysine and the lysine at position B29 is replaced by glutamic acid. These structural modifications decrease hexamer formation, stabilize insulin glulisine monomers and increase the rate of absorption and onset of action compared to human insulin.
|
| has pharmacological target | |
| induces | |
| activates | |
| type | |
| AHFScode | 68:20.08
|
| xref |
PDRhealth:http://www.pdrhealth.com/drugs/rx/rx-mono.aspx?contentFileNam
Drugs.com:http://www.drugs.com/mtm/insulin-glulisine.html
Wikipedia:http://en.wikipedia.org/wiki/Insulin_glulisine
National Drug Code Directory:0088-2502-05
RxList:http://www.rxlist.com/apidra-drug.htm
PharmGKB:PA164760859
See more
See less
|
| CASRN | 207748-29-6
|
| prefixIRI | obo2:dinto_DB01309
|
| may interact with |
See more
See less
|
| DBBrand |
apidra solostar
apidra
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |